Cargando…
MDM2 induces EMT via the B-Raf signaling pathway through 14-3-3
MDM2 proto-oncogene, E3 ubiquitin protein ligase (MDM2) is a well-known oncogene and has been reported to be closely associated with epithelial-to-mesenchymal transition (EMT). The present study first demonstrated that the expression levels of MDM2 were markedly increased in TGF-β-induced EMT using...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129971/ https://www.ncbi.nlm.nih.gov/pubmed/33955525 http://dx.doi.org/10.3892/or.2021.8071 |
_version_ | 1783694417334370304 |
---|---|
author | Ou, Mengting Xu, Xichao Chen, Ying Li, Li Zhang, Lu Liao, Yi Sun, Weichao Quach, Christine Feng, Jianguo Tang, Liling |
author_facet | Ou, Mengting Xu, Xichao Chen, Ying Li, Li Zhang, Lu Liao, Yi Sun, Weichao Quach, Christine Feng, Jianguo Tang, Liling |
author_sort | Ou, Mengting |
collection | PubMed |
description | MDM2 proto-oncogene, E3 ubiquitin protein ligase (MDM2) is a well-known oncogene and has been reported to be closely associated with epithelial-to-mesenchymal transition (EMT). The present study first demonstrated that the expression levels of MDM2 were markedly increased in TGF-β-induced EMT using quantitative PCR and western blotting. In addition, MDM2 was demonstrated to be associated with pathological grade in clinical glioma samples by immunohistochemical staining. Furthermore, overexpression of MDM2 promoted EMT in glioma, lung cancer and breast cancer cell lines using a scratch wound migration assay. Subsequently, the present study explored the mechanism by which MDM2 promoted EMT and revealed that MDM2 induced EMT by upregulating EMT-related transcription factors via activation of the B-Raf signaling pathway through tyrosine 3-monooxygenase activation protein ε using RNA sequencing and western blotting. This mechanism depended on the p53 gene. Furthermore, in vivo experiments and the colony formation experiment demonstrated that MDM2 could promote tumor progression and induce EMT via the B-Raf signaling pathway. Since EMT contributes to increased drug resistance in tumor cells, the present study also explored the relationship between MDM2 and drug sensitivity using an MTT assay, and identified that MDM2 promoted cell insensitivity to silibinin treatment in an EMT-dependent manner. This finding is crucial for the development of cancer therapies and can also provide novel research avenues for future biological and clinical studies. |
format | Online Article Text |
id | pubmed-8129971 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-81299712021-05-19 MDM2 induces EMT via the B-Raf signaling pathway through 14-3-3 Ou, Mengting Xu, Xichao Chen, Ying Li, Li Zhang, Lu Liao, Yi Sun, Weichao Quach, Christine Feng, Jianguo Tang, Liling Oncol Rep Articles MDM2 proto-oncogene, E3 ubiquitin protein ligase (MDM2) is a well-known oncogene and has been reported to be closely associated with epithelial-to-mesenchymal transition (EMT). The present study first demonstrated that the expression levels of MDM2 were markedly increased in TGF-β-induced EMT using quantitative PCR and western blotting. In addition, MDM2 was demonstrated to be associated with pathological grade in clinical glioma samples by immunohistochemical staining. Furthermore, overexpression of MDM2 promoted EMT in glioma, lung cancer and breast cancer cell lines using a scratch wound migration assay. Subsequently, the present study explored the mechanism by which MDM2 promoted EMT and revealed that MDM2 induced EMT by upregulating EMT-related transcription factors via activation of the B-Raf signaling pathway through tyrosine 3-monooxygenase activation protein ε using RNA sequencing and western blotting. This mechanism depended on the p53 gene. Furthermore, in vivo experiments and the colony formation experiment demonstrated that MDM2 could promote tumor progression and induce EMT via the B-Raf signaling pathway. Since EMT contributes to increased drug resistance in tumor cells, the present study also explored the relationship between MDM2 and drug sensitivity using an MTT assay, and identified that MDM2 promoted cell insensitivity to silibinin treatment in an EMT-dependent manner. This finding is crucial for the development of cancer therapies and can also provide novel research avenues for future biological and clinical studies. D.A. Spandidos 2021-07 2021-05-05 /pmc/articles/PMC8129971/ /pubmed/33955525 http://dx.doi.org/10.3892/or.2021.8071 Text en Copyright: © Ou et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Ou, Mengting Xu, Xichao Chen, Ying Li, Li Zhang, Lu Liao, Yi Sun, Weichao Quach, Christine Feng, Jianguo Tang, Liling MDM2 induces EMT via the B-Raf signaling pathway through 14-3-3 |
title | MDM2 induces EMT via the B-Raf signaling pathway through 14-3-3 |
title_full | MDM2 induces EMT via the B-Raf signaling pathway through 14-3-3 |
title_fullStr | MDM2 induces EMT via the B-Raf signaling pathway through 14-3-3 |
title_full_unstemmed | MDM2 induces EMT via the B-Raf signaling pathway through 14-3-3 |
title_short | MDM2 induces EMT via the B-Raf signaling pathway through 14-3-3 |
title_sort | mdm2 induces emt via the b-raf signaling pathway through 14-3-3 |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129971/ https://www.ncbi.nlm.nih.gov/pubmed/33955525 http://dx.doi.org/10.3892/or.2021.8071 |
work_keys_str_mv | AT oumengting mdm2inducesemtviathebrafsignalingpathwaythrough1433 AT xuxichao mdm2inducesemtviathebrafsignalingpathwaythrough1433 AT chenying mdm2inducesemtviathebrafsignalingpathwaythrough1433 AT lili mdm2inducesemtviathebrafsignalingpathwaythrough1433 AT zhanglu mdm2inducesemtviathebrafsignalingpathwaythrough1433 AT liaoyi mdm2inducesemtviathebrafsignalingpathwaythrough1433 AT sunweichao mdm2inducesemtviathebrafsignalingpathwaythrough1433 AT quachchristine mdm2inducesemtviathebrafsignalingpathwaythrough1433 AT fengjianguo mdm2inducesemtviathebrafsignalingpathwaythrough1433 AT tangliling mdm2inducesemtviathebrafsignalingpathwaythrough1433 |